Social media platforms, such as social networking sites (SNS), have become integral to our daily lives. Initially utilized as web-based tools, the advent of smartphones capable of internet access combined with our growing reliance on these devices has led to an increased use of and addiction to SNSs, including social networks, forums, Twitter, blogs, Instagram, and Facebook (
1-
3). Indeed, the interactive nature of cyberspace, which allows for immediate commenting and response checking, poses a significant risk of SNS addiction (
4).
Social networking sites addiction falls under the broader category of internet addiction and impacts individuals across all demographics and age brackets (
5,
6). It is characterized by an unhealthy psychological dependence on SNSs, marked by compulsive engagement and the need to check and use these platforms (
5) constantly. Andreassen and Pallesen describe SNS addiction as an excessive worry about SNSs, a strong desire to log on and engage with them, and dedicating a substantial amount of time and effort to these activities. This obsession can detrimentally affect individuals' social engagements, academic pursuits, careers, personal relationships, mental health, and overall well-being (
7).
Symptoms of SNS addiction, akin to those observed in other types of addiction, encompass withdrawal symptoms, relapse, tolerance, isolation, conflicts, and mood modification (
6,
8). Additionally, frequent use of SNS and smartphones can lead to mental (such as depression, anxiety, and sleep disorders), physical (including visual disturbances and musculoskeletal issues like neck pain), and social (such as traffic issues and accidents) disorders (
9,
10). Behavioral addictions, such as excessive use of social networking sites, similar to drug addiction, are linked with disruptions in dopaminergic regulation (
11,
12). Prior research indicates that normal regulation of striatal dopamine activity by the prefrontal cortex signaling is disrupted, suggesting that reduced striatal dopamine activity may reflect abnormal regulation of the mesolimbic dopamine system by the prefrontal cortex (
13).
Dopamine receptors are categorized into five main subtypes (D1-D5) (
14). These receptors are split into two groups based on pharmacological characteristics; the D1-like group, comprising D1 and D5 receptors, shares pharmacological structure and sensitivity and stimulates intracellular cAMP levels. The D2-like group includes D2, D3, and D4 receptors, which are structurally similar and inhibit intracellular cAMP levels (
15,
16). Metabotropic dopamine receptors initiate the formation of second messengers, which then either trigger or inhibit the activation of specific cellular signaling pathways (
17). Studies have shown that individuals with substance abuse disorders (including opium, cannabis, nicotine, etc.) and those with internet addiction exhibit a decreased availability of D2 and D3 receptors (
11,
18-
20).
Peripheral blood lymphocytes serve as effective and accessible indicators for assessing changes in neurotransmitter receptors, such as dopamine receptor genes, and are a suitable proxy for gene expression analysis in the brain (
21). Although mRNA expressions of D1 and D2 are prevalent in the brain, evidence for their expression in peripheral blood lymphocytes remains insufficient (
22).